S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for PTC Therapeutics Inc [PTCT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
60.00%
return 3.22%
SELL
40.00%
return 1.53%
Last Updated17 May 2024 @ 16:00

-2.75% $ 33.10

BUY 136348 min ago

@ $25.11

Issued: 14 Feb 2024 @ 15:41


Return: 31.80%


Previous signal: Feb 13 - 15:43


Previous signal: Sell


Return: 3.95 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):
Profile picture for PTC Therapeutics Inc

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders...

Stats
Today's Volume 626 199
Average Volume 864 498
Market Cap 2.54B
EPS $0 ( 2024-04-25 )
Next earnings date ( $-1.230 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.30
ATR14 $0.0470 (0.14%)
Insider Trading
Date Person Action Amount type
2024-05-08 Southwell David P Sell 1 650 Common Stock
2024-05-07 Golden Lee Scott Sell 175 Common Stock
2024-04-19 Klein Matthew B. Sell 3 361 Common Stock
2024-04-17 Pauwels Eric Sell 787 Common Stock
2024-04-17 Klein Matthew B. Sell 1 307 Common Stock
INSIDER POWER
73.53
Last 98 transactions
Buy: 1 038 941 | Sell: 203 269

Volume Correlation

Long: -0.44 (neutral)
Short: -0.32 (neutral)
Signal:(38.59) Neutral

PTC Therapeutics Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PTC Therapeutics Inc Correlation - Currency/Commodity

The country flag 0.14
( neutral )
The country flag 0.38
( neutral )
The country flag 0.00
( neutral )
The country flag 0.61
( weak )
The country flag 0.28
( neutral )
The country flag -0.02
( neutral )

PTC Therapeutics Inc Financials

Annual 2023
Revenue: $937.82M
Gross Profit: $649.70M (69.28 %)
EPS: $-8.37
FY 2023
Revenue: $937.82M
Gross Profit: $649.70M (69.28 %)
EPS: $-8.37
FY 2022
Revenue: $698.80M
Gross Profit: $654.12M (93.61 %)
EPS: $-7.79
FY 2021
Revenue: $538.59M
Gross Profit: $506.27M (94.00 %)
EPS: $-7.26

Financial Reports:

No articles found.

PTC Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

PTC Therapeutics Inc

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators